Clinical research in cardiology : official journal of the German Cardiac Society · 2026
Right ventricular dysfunction: an overlooked predictor of sudden cardiac death and arrhythmic events-a meta-analysis.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Chiba Toshinori, Beblo Amelie, Wainstejn Nora, Lueg Julia, Hättasch Robert, Hohendanner Felix, Tscholl Verena, Dagres Nikolaos, Hindricks Gerhard, Haverkamp Wilhelm
Аннотация
BACKGROUND: Right ventricular (RV) dysfunction has emerged as a potential predictor of adverse cardiac outcomes, including sudden cardiac death (SCD) and severe ventricular arrhythmias (VAs). To clarify the role of RV dysfunction in arrhythmic risk assessment, we conducted a systematic review and meta-analysis to evaluate its prognostic value for SCD and VA.
METHODS: A systematic search of PubMed, Embase, and Web of Science was conducted from inception to February 2025. The primary endpoint was a composite of SCD or severe VA, including ventricular tachycardia, ventricular fibrillation, or appropriate implantable cardioverter-defibrillator therapy. RV dysfunction was defined as impaired RV fractional area change, RV ejection fraction, or RV strain. A random-effects model was used to calculate pooled odds ratios (ORs) and mean differences (MDs) with 95% confidence intervals (CIs).
RESULTS: Of 1296 identified articles, seven studies comprising 1475 patients met the inclusion criteria. RV dysfunction was present in 541 patients. The mean follow-up duration was 2.9 years. RV dysfunction was significantly associated with an increased risk of SCD and VA (OR 3.69; 95% CI 2.40-5.66; p < 0.01). Secondary analysis showed that patients who experienced SCD or VA had significantly lower RVFAC compared to those without events (MD - 5.67; 95% CI - 8.73 to - 2.60; p < 0.01), whereas LVEF did not differ significantly between groups (MD - 0.59; 95% CI - 4.10 to 2.92; p = 0.74).
CONCLUSIONS: RV dysfunction is associated with an increased risk of SCD and VA, indicating that RV parameters may hold prognostic value in arrhythmic risk stratification.
METHODS: A systematic search of PubMed, Embase, and Web of Science was conducted from inception to February 2025. The primary endpoint was a composite of SCD or severe VA, including ventricular tachycardia, ventricular fibrillation, or appropriate implantable cardioverter-defibrillator therapy. RV dysfunction was defined as impaired RV fractional area change, RV ejection fraction, or RV strain. A random-effects model was used to calculate pooled odds ratios (ORs) and mean differences (MDs) with 95% confidence intervals (CIs).
RESULTS: Of 1296 identified articles, seven studies comprising 1475 patients met the inclusion criteria. RV dysfunction was present in 541 patients. The mean follow-up duration was 2.9 years. RV dysfunction was significantly associated with an increased risk of SCD and VA (OR 3.69; 95% CI 2.40-5.66; p < 0.01). Secondary analysis showed that patients who experienced SCD or VA had significantly lower RVFAC compared to those without events (MD - 5.67; 95% CI - 8.73 to - 2.60; p < 0.01), whereas LVEF did not differ significantly between groups (MD - 0.59; 95% CI - 4.10 to 2.92; p = 0.74).
CONCLUSIONS: RV dysfunction is associated with an increased risk of SCD and VA, indicating that RV parameters may hold prognostic value in arrhythmic risk stratification.